[A case report of pulmonary actinomycosis and review of the literature].

Objective: To improve the awareness of primary pulmonary actinomycosis.

Method: One case of primary endobronchial actinomycosis was reported and 187 cases of primary pulmonary actinomycosis reported in the literature were reviewed.

Results: A 66-year-old female had had recurrent cough, sputum production and fever for 4 years.

A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population.

Objective: To evaluate the efficacy and safety of oseltamivir treatment in a population at high risk for influenza.

Research Design And Methods: This was a randomized, open-label, controlled trial involving Chinese patients with chronic respiratory diseases (chronic bronchitis, obstructive emphysema, bronchial asthma or bronchiectasis) or chronic cardiac disease. Patients showing symptoms of influenza were randomly assigned to receive oral oseltamivir 75 mg twice daily for 5 days (oseltamivir group), or symptomatic treatment (control group) within 48 h after symptom onset.

[A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population].

Objective: To evaluate the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population.

Methods: A randomized, open, control trial was conducted from Nov. 2002 to Feb.